Hepatitis web study H EPATITIS W EB S TUDY Christian B. Ramers, MD, MPH Assistant Medical Director, Family Health Centers of San Diego HIV/HCV Distance.

Slides:



Advertisements
Similar presentations
By: Lisa Iacopetti Angela Bravo Dominic Cruz
Advertisements

Advances in the Treatment of Chronic Hepatitis C Gregory T Everson, MD Professor of Medicine Director of Hepatology University of Colorado Denver.
Hcv infection and management in advanced liver disease
Integration of Viral Hepatitis Prevention with STD Prevention: What Health Professionals Should Know Presenter: Jay Todd, Training and Public Education.
Hepatitis C in Minority Populations Andrea E. Reid, MD, MPH Veterans Affairs Medical Center Washington, DC.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Liver Disease and Thalassaemia George Constantinou.
Screening for Hepatitis C Virus Infection Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Hepatitis web study H EPATITIS W EB S TUDY Hepatitis A: Epidemiology Presentation Prepared by: David Spach, MD and Nina Kim, MD Last Updated: May 31, 2011.
Hepatitis C Best Practice Guidelines Susan Thompson, RN, MPH September 2009.
Hepatitis B: Epidemiology
Hepatitis C In Alaska’s Department of Corrections
Hepatitis C Prepared by Division of Viral Hepatitis Centers for Disease Control and Prevention Revised by Jill Gallin, CPNP Assistant Professor of Clinical.
Hepatitis C Rapid Antibody Testing Among At-Risk Populations, Arizona, 2014 Felicia McLean Public Health Associate Office for State, Tribal, Local and.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
‏Hepatitis B Eliminating Transmission Preventing Disease* John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention * The.
 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)
Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Greenview Hepatitis C Fund Deborah Green Home: Cell: /31/2008.
Module 3: HCV prevalence and course of HCV infection.
Hepatitis C Education & Awareness. Women In Government Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women.
Modelled impact of antiviral therapy on the future burden of HCV disease in Scotland Testing/Treatment/Care Working Group, 11 th Sept 2007.
Managing Hepatitis C: An Unprecedented Correctional Healthcare Challenge ASCA/CCHA meeting Phoenix, AZ RADM Newton E. Kendig Assistant Director/Medical.
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Hepatitis C- Global and National Perspective Dr Allister Grant Consultant Hepatologist University Hospitals Leicester NHS Trust.
Wyoming Department of Health Communicable Diseases
Hepatitis web study H EPATITIS W EB S TUDY David Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington School of Medicine.
Division of Viral Hepatitis
This is the most comprehensive compilation of epidemiological information on Hepatitis C Graciously provided by the University Hepatitis Center (last updated.
HCV Diagnosis. Features of Hepatitis C Virus Infection Incubation periodAverage 6-7 weeks Range 2-26 weeks Acute illness (jaundice)Mild (
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
What is hepatitis B? Hepatitis B is a virus that infects the liver.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.
21/2/ Viral Hepatitis B (HBV) Associate Professor Family and Community Medicine Department King Saud University.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
The Swiss Population In 2001 Resident population: 7,258,500 Population density: 176 per Km 2 Foreign nationals: 20.1% (~1,460,000) Excess of births over.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
Pennsylvania: The State of HCV 2015
Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.
Viral Hepatitis Program Management of Babies Born to HBsAg- Positive Mothers Vickie Weeast Perinatal Hepatitis B Case.
Hepatitis C Dr R V S N Sarma., M.D Consultant Physician.
Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.
From discovery to cure in 25 years -- the Hepatitis C story Mel Krajden MD, FRCPC Medical Head, Hepatitis Acting Medical Director, Public Health Laboratory.
Alcohol Drugs and Hepatitis C, Brewing up a perfect storm COSLA Haymarket, Edinburgh 24 June 2015 Epidemiological overview Professor David Goldberg, Health.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
Nancy Reau, MD University of Chicago Chicago, Illinois Mark S. Sulkowski, MD Johns Hopkins University School of Medicine Baltimore, Maryland Clinical Outcomes.
What is the contribution of alcohol to liver disease in the hepatitis C infected population. The epidemiological evidence Hamish Innes Research Fellow.
Setting the Scene. Non A, non B Hepatitis  Early 1970’s recognised that 2/3 of post transfusional hepatitis were –ve for both Hep A & Hep B Non Hep A.
HBV. Overview of the Epidemiology of Hepatotropic Viruses.
Template ID: junglegreens Size: 36x48 Impact of Hepatitis C Screening in Outpatient Population Madhuri Chandnani MD, Pallavi Pothuri MD, Michael Stevens.
Date of download: 9/17/2016 From: The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions Ann Intern Med. 2014;161(3):
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Hepatitis C.
Hepatitis C: Overview and Epidemiology
Addressing Viral Hepatitis
Stacey B Trooskin MD PhD
Hepatitis C Incidence and Prevalence in the U.S.
Summary Report: Management of Hepatitis C in Prisons
Viral Hepatitis in Correctional Settings
Hepatitis C Screening Best Practices Jenitza Serrano-Feliciano M.D
RISK R isk of Perinatal and Early Childhood Infection
Key Point Approximately one-third of individuals diagnosed with hepatitis C virus (HCV) infection are not able to identify the source of their infection1.
HCV epi overview Brigg Reilley, NPAIHB,
Progress in Facilitating National HCV Prevention
Hepatitis C case-finding – An opportunity for community pharmacy
Managing Hepatitis C in Vermont
Presentation transcript:

Hepatitis web study H EPATITIS W EB S TUDY Christian B. Ramers, MD, MPH Assistant Medical Director, Family Health Centers of San Diego HIV/HCV Distance Education Specialist, Northwest AETC University of Washington School of Medicine Hepatitis C Testing Recommendations Last Updated: February 28, 2013

Hepatitis web study Disclosure Information Speaker’s Bureau and Consultant: Gilead Sciences

Hepatitis web study Hepatitis web study  CDC HCV Testing Recommendation  Rationale for Birth Cohort HCV Testing Recommendations  Goals and Potential Impact of HCV Birth Cohort Testing Hepatitis C Testing Recommendations in the U.S.

Hepatitis web study Hepatitis web study CDC HCV Testing Recommendations

Hepatitis web study 1998 – CDC Risk-Based HCV Screening Recommendations Source: CDC and Prevention. Persons who ever injected illegal drugs Persons with selected medical conditions, including - receipt of clotting factor concentrates produced before 1987; - ever on chronic (long-term) hemodialysis; and - persistently abnormal alanine aminotransferase levels Prior recipients of transfusions or organ transplants (before July 1992)  HCV screening based on risk for infection: Healthcare, emergency medical, and public safety workers after needle sticks, sharps, or mucosal exposures to HCV-positive blood Children born to HCV-positive women  HCV screening based on recognized exposure:

Hepatitis web study Hepatitis web study Source: CDC and Prevention. MMWR. 2012:RR61:1-32.

Hepatitis web study 2012 CDC Birth Cohort HCV Testing Recommendations In addition to testing adults of all ages at risk for hepatitis C virus:  Adults born during 1945 to 1965 should receive 1-time testing for HCV without prior ascertainment of HCV risk.  All persons identified with HCV infection should receive: - A brief alcohol screening and intervention as clinically indicated, - Referral to appropriate care and treatment services for HCV infection, - Post-test counseling Source: Source: CDC and Prevention. MMWR. 2012:RR61:1-32.

Hepatitis web study Hepatitis C Testing Methods YYY Screening: Hepatitis C Antibody Testing - Highly sensitive and specific - Reactive test indicates current or resolved infection Supplemental: Nucleic Acid Testing - Quantitative and qualitative HCV RNA tests used - Positive test indicates active infection

Hepatitis web study Hepatitis web study Rationale for Birth Cohort HCV Testing Recommendations

Hepatitis web study 1968 World Health Organization Guidelines Criteria for New Screening Programs When considering general public health screening programs, the following factors should be considered:  Relevance: Is the condition an important public health problem with a well-understood natural history and a latent phase?  Feasibility: Is there an effective intervention? Is a screening test available, easy to use, accurate, and acceptable to the population?  Effectiveness: Does early diagnosis and treatment affect outcomes?  Cost Effectiveness: Is the cost of the screening program worth the investment in terms of health benefit gained? Adapted from: Wilson JMG and Jungner G. Principles and Practice of Screening for Disease. WHO

Hepatitis web study Sources: Armstrong GL, et al. Ann Intern Med. 2006;144: Chak E, et al. Liver Int. 2011;31: Estimated Prevalence of Chronic Active Hepatitis C in U.S Million Persons Living with Chronic HCV

Hepatitis web study Source: Ly KN, et al. Ann Intern Med. 2012:156: Age-Adjusted Mortality Rates from HBV, HCV, & HIV United States, Rate per 100,000 PY Year HIV Hepatitis C Hepatitis B

Hepatitis web study Source: Rein DR, et al. Dig Liver Dis. 2011:43: Forecasted Annual HCV-Related Deaths in the United States Persons with Chronic Hepatitis C and no Cirrhosis in 2005 Number Year 2010 Deaths ,000 35,000 30,000 25,000 20,000 15,000 10,000 5, ,000

Hepatitis web study Source: Rein DR, et al. Dig Liver Dis. 2011:43: Forecasted Annual HCV-Related Deaths in the United States Persons with Chronic Hepatitis C and no Cirrhosis in 2005 Peak

Hepatitis web study Source: Rein DR, et al. Dig Liver Dis. 2011:43: Forecasted Annual HCV-Related Deaths in the United States Persons with Chronic Hepatitis C and no Cirrhosis in 2005 Number Year 2010 Deaths ,000 35,000 30,000 25,000 20,000 15,000 10,000 5, ,000 Without treatment an estimated 1,071,229 persons will have died from hepatitis C by 2060

Hepatitis web study Source: Denniston M, et al. Hepatology. 2012:55: NHANES Survey, United States, Awareness of HCV Infection Status Unaware of HIV infection 21% Knowledge of HCV Infection

Hepatitis web study Source: WHO Hepatitis C Fact Sheet Burden of disease related to HCV OutcomeKey Facts Cirrhosis Develops in 20% of those who are chronically infected with HCV over years Decompensated Cirrhosis High risk of mortality from ruptured esophageal varices, bacterial peritonitis, hepatorenal syndrome/renal failure, encephalopathy Hepatocellular Carcinoma Fastest growing Cancer in the US 76% associated with chronic HCV infection 4% annual incidence in those with cirrhosis Liver Transplantation HCV responsible for 65% of liver transplants worldwide HCV Mortality Estimated at 16,000/year Likely to peak ~2030 Burden of Liver disease expected to triple in next yrs

Hepatitis web study Therapy for Hepatitis C: Historical Milestones Timeline 2011

Hepatitis web study Therapy for Hepatitis C Projected SVR Rates with Multiple DAAs Timeline

Hepatitis web study Source: Armstrong GL, et al. Ann Intern Med. 2006;144: NHANES Survey: United States, and Prevalence of HCV Antibody, by Year of Birth Year of Birth HCV Prevalence(%) – –

Hepatitis web study Source: Armstrong GL, et al. Ann Intern Med. 2006;144: NHANES Survey: United States, and Prevalence of HCV Antibody, by Year of Birth Year of Birth HCV Prevalence(%) – –

Hepatitis web study Rationale for One-Time HCV Testing of All Persons Born in United States during 1945 to 1965 Hepatitis C is a major current & future health problem in United States Testing can identify persons before onset of severe HCV-related disease Hepatitis C infection can be cured with treatment Bulk of HCV problem in United States involves persons born Approximately 50% of persons with HCV remain unaware of HCV status

Hepatitis web study Hepatitis web study Goals and Projected Impact of Birth-Cohort Screening

Hepatitis web study Goals for Birth Cohort Hepatitis C Testing in U.S. Improve Survival & Quality of Life Improve Survival & Quality of Life Prevent New HCV Infections HCV Testing HCV Diagnosis Treat HCV Link to Care for HCV

Hepatitis web study Goals for Birth Cohort Hepatitis C Testing in U.S. Improve Survival & Quality of Life Improve Survival & Quality of Life Prevent New HCV Infections HCV Testing HCV Diagnosis Link to Care for HCV

Hepatitis web study HCV Testing of Persons in Birth Cohort CDC Recommendations for Post Test Counseling Refer or obtain advice for care of HCV - experienced primary care provider or specialist Educate patient on how to protect liver from further harm - Immunization against Hepatitis A and B - Brief alcohol screening and intervention - Limit exposure to hepatotoxic drugs (e.g. acetaminophen ) Counsel obese patients on diet & weight Loss - Especially BMI ≥25kg/m 2 Advise on decreasing risk of transmission to others - Donation of blood, tissue, semen - Use of razors, toothbrushes, nail clippers Source: CDC and Prevention. MMWR. 2012:61(RR-4):1-32.

Hepatitis web study HCV Testing of Persons Born Projected Benefit of One Time Birth Cohort Testing Clinical Outcomes Associated with Risk Based versus Birth Cohort HCV Testing Source: Rein DB, et al. Ann Intern Med. 2012:156:

Hepatitis web study HCV Testing of Persons Born Projected Benefit of One Time Birth Cohort Testing Cases Averted with Birth Cohort HCV Testing versus Risk Based HCV Testing Source: Rein DB, et al. Ann Intern Med. 2012:156:

Hepatitis web study Source: Rein, DB et al Ann Intern Med 2012:156: HCV Testing of Persons Born Cost Effectiveness Compared with other Screening Tests

Hepatitis web study Hepatitis web study  Perform one-time HCV testing of all persons born  Continue risk-based HCV screening  Sound rationale exists for birth-cohort screening  Potential for large impact of birth-cohort testing CDC Birth Cohort HCV Testing Recommendations in U.S. : Summary

Hepatitis web study Hepatitis web study End This presentation is brought to you by Hepatitis Web Study & the Hepatitis C Online Course Funded by a grant from the Centers for Disease Control and Prevention